about
Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic ReviewSelective progesterone receptor modulators: an updateContraception today.Different bleeding patterns with the use of levonorgestrel intrauterine system: are they associated with changes in uterine artery blood flow?Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis.Observational, prospective, multicentre study to evaluate the effects of counselling on the choice of combined hormonal contraceptives in Italy--the ECOS (Educational COunselling effectS) studyHormonal contraception: present and future.Cryopreservation protocol for human biliary tree stem/progenitors, hepatic and pancreatic precursorsThe Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center.Second-trimester induced abortions in two tertiary centres in Rome.Reasons for requesting emergency contraception: a survey of 506 Italian women.Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum.Contraception: a social revolution.Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulationEmergency contraception: a reviewPharmacodynamics of combined estrogen-progestin oral contraceptives: 4. Effects on uterine and cervical epitheliaSelective progesterone receptor modulators 1: use during pregnancySelective progesterone receptor modulators 2: use in reproductive medicineSelective progesterone receptor modulators 3: use in oncology, endocrinology and psychiatry
P50
Q26770436-3CF532D1-A0A3-47D8-B9DE-24466AF1C5B0Q28239255-710BE4EA-CA1E-4C97-B074-4C9C041B1814Q30359932-BFA63802-A4C2-4000-A993-05B281C14BADQ33598011-89813EC5-B82C-49D4-B650-18F5F9A29CE3Q34707880-A6B93D67-FF61-4FB8-86F1-8D583C73311EQ35761573-65B2EDB6-71E3-4A01-B2CE-025BE2D56CF1Q37386960-E4ABE715-FE7E-43E2-8861-F4C138459414Q41075630-EDB00AC3-843A-4D7E-81AE-8B0981F24126Q43551307-3879DDF0-A4C0-48E7-9E21-65B228C9B1DEQ44210164-20A3576B-C614-4832-ABFD-91707A22D4F4Q44702905-EA453732-185A-4B40-A849-1DB88FB30BF8Q45246557-89C17F3A-E229-4793-A4DE-F65E618E4565Q48119725-17930D35-4920-4905-B9B8-5EF46F0CE5B4Q51095548-BDDF8B83-D0FA-4B8E-A878-98B654C1EBDFQ51184356-BF78AB0A-A1C1-4F47-BF39-50C317B7E13FQ51575434-FD0498DF-CECF-42F1-ABA9-7794727318CBQ53237631-67CDF186-53B0-4939-BA9B-4230A647F4B4Q57457277-913D105E-ED3D-4D66-96A5-865F616E9F80Q80728327-2F68CAFA-B910-47AC-A0C0-720DC83808CAQ92896338-0C491638-0104-4E27-99AC-58C1BD8D81E8Q94706524-87CB04EC-8B4D-4FD4-96BD-A48C5EB55748Q94706526-6346461A-475F-4EB9-B386-DF2D31DD3D34Q94706529-38EA9E70-405A-4351-AC64-91F4FD50780D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlo Bastianelli
@ast
Carlo Bastianelli
@en
Carlo Bastianelli
@es
Carlo Bastianelli
@nl
Carlo Bastianelli
@sl
type
label
Carlo Bastianelli
@ast
Carlo Bastianelli
@en
Carlo Bastianelli
@es
Carlo Bastianelli
@nl
Carlo Bastianelli
@sl
prefLabel
Carlo Bastianelli
@ast
Carlo Bastianelli
@en
Carlo Bastianelli
@es
Carlo Bastianelli
@nl
Carlo Bastianelli
@sl
P106
P1153
23026601600
P21
P31
P496
0000-0003-3141-4022